SPY334.24-0.09 -0.03%
DIA273.48-0.42 -0.15%
IXIC11,089.18-18.89 -0.17%
新闻
AMAG
--
0.00%
--
AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Lags Revenue Estimates
AMAG Pharmaceuticals (AMAG) delivered earnings and revenue surprises of 16.67% and -6.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 1天前
AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update
Financial guidance reissued to include EBITDA-positive projection for second-half 2020 Strategic shift and momentum build through recent business development activitiesBrian Piekos promoted to Chief Financial OfficerConference call scheduled for 8:00 a.m. ET
GlobeNewswire · 1天前
AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020
WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will host
GlobeNewswire · 07/28 12:00
Palatin Tech puts end to Vyleesi license agreement with Amag Pharma
Seeking Alpha · 07/27 12:39
AMAG Pharmaceuticals Completes Divestment Of Women's Health Assets
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) todayannounced AMAG and Palatin Technologies, Inc. have mutually terminated the January 2017 license agreement pursuant to which
Benzinga · 07/27 11:33
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) --  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Te
GlobeNewswire · 07/27 11:30
Palatin Technologies Terminates its Agreement Granting AMAG Pharma Exclusive North American Reights to Market Vyleesi
Benzinga · 07/27 11:03
Why AMAG's Stock Is Moving Today
AMAG Pharmaceuticals (NASDAQ: AMAG) shares are trading lower after the company announced it has entered into an exclusive licensing agreement with B.V. to commercialize Ciraparantag in Europe, Australia and New Zealand.
Benzinga · 07/24 16:04
AMAG Pharmaceuticals shares are trading higher after the company on Thursday announced it has entered into an exclusive licensing agreement with B.V. to commercialize Ciraparantag in Europe, Australia and New Zealand.
Benzinga · 07/24 15:31
AMAG Pharma inks licensing deal for ciraparantag
Seeking Alpha - Article · 07/23 11:49
AMAG Pharmaceuticals shares are trading higher after the company announced it has entered into an exclusive licensing agreement with B.V. to commercialize Ciraparantag in Europe, Australia and New Zealand. AMAG will receive a $30 million upfront payment and is eligible for up to $260 million in milestones.
Benzinga · 07/23 11:36
AMAG Pharmaceuticals And Norgine B.V. Enter Into Exclusive Licensing Agreement To Commercialize Ciraparantag In Europe, Australia And New Zealand; AMAG Receives $30M Upfront Payment, Eligible For Up To $260M In Milestones
Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   Collaboration further advances
Benzinga · 07/23 11:16
AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand
Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   Collaboration further advances the development of ciraparantagWALTHAM, Mass. and A
GlobeNewswire · 07/23 11:13
AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis
GlobeNewswire · 07/12 13:30
Hedge Funds Still Kind Of Bullish On AMAG Pharmaceuticals, Inc. (AMAG)
Insider Monkey · 07/06 15:00
Forensic Value Stock Analysis: Top Positive And Negative Scoring Stocks Mid-Year 2020
Seeking Alpha - Article · 07/06 09:44
Edited Transcript of AMAG earnings conference call or presentation 11-May-20 12:00pm GMT
Q1 2020 AMAG Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents · 06/11 17:55
AMAG Pharma's finance chief bids adieu
Seeking Alpha - Article · 06/11 12:17
AMAG Pharmaceuticals Announces Leadership Changes
GlobeNewswire · 06/11 12:00